XENON PHARMACEUTICALS INC. (XENE)
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
Webull Announces Termination of Standby Equity Purchase Agreement
Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory
Via to Announce First Quarter 2026 Financial Results on May 12, 2026
LogProstyle Announces Discontinuation of Share Repurchase Program and Consideration of Possible Special Dividend
Amentum Secures $425 Million Contract to Support California’s Aerial Firefighting Operations
LiveRamp and Akkio Partner to Enable Seamless Measurement and Stronger Insights for Marketers Using AI
DeFi Development Corp. Releases March 2026 Recap Highlighting Strategic Execution, Research Expansion, and SPS Growth
Runway Growth Finance Corp. Closes Acquisition of SWK Holdings Corporation and Provides First Quarter 2026 Business and Portfolio Update
DoubleVerify to Announce First Quarter 2026 Financial Results on May 6, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference
Prairie Operating Co. Announces Agreement to Further Extend Series F Anniversary Warrant Issuance Date
Crane Company Announces Date for First Quarter 2026 Earnings Release and Teleconference
SecureTech Innovations Nominates Robert V. Castro, CPA, CGMA, to Board of Directors and Audit Committee
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership